← All reports
RX
Pharmaceuticals
India Pharmaceuticals
From the US generics peak to brands, biologics and contract chemistry
Industry report · Oct 2026
India Pharmaceuticals
India brands, CDMO and specialty look structurally stronger; US-generic earnings face a post-gRevlimid reset and a dated tariff clock.
Further reading
- Healing the world: a roadmap for making India a global pharma exports hubIPA and Bain & Company ↗
- The US-India medicine partnershipIQVIA for IPA ↗
- Indian pharmaceutical industry: the way forwardIndian Pharmaceutical Alliance ↗
- Annual reportsDepartment of Pharmaceuticals ↗
- Pharmaceutical industry in IndiaIBEF ↗
- Indian Pharmaceutical AllianceIPA ↗
- Export data and publicationsPharmexcil ↗
- Reports and publicationsIQVIA Institute for Human Data Science ↗